BlossomHill Therapeutics

BlossomHill Therapeutics is a small molecule drug design and development company focused on addressing unmet medical needs in oncology and autoimmune diseases. 

IPO
Biotech

BlossomHill, Latigo outshine IPO expectations

Blossom Hill Therapeutics and Latigo Biotherapeutics each raised at least 30% more than expected in their respective IPOs.
Will Maddox Aug 7, 2026 11:10am
Apple trees in an orchard

BlossomHill eyes $112M IPO harvest to fund Tagrisso challenger

Aug 3, 2026 9:18am
Field of flowers with a rainbow behind

BlossomHill eyes IPO to grow taller in crowded cancer fields

Jul 17, 2026 12:08pm
parachute snow mountains

Amylyx preps for GLP-1 launch with new CCO—Chutes & Ladders

Jan 10, 2025 8:30am
crocus spring flowers bloom blossom purple violet

A new biotech blooms with $100M to take on small molecules

Feb 29, 2024 9:30am